{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:10:24Z","timestamp":1790161824044,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11655-026-4246-1","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:57:14Z","timestamp":1784073434000},"page":"894-902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated Network Pharmacology and Proteomics Reveal Anti-tumor Mechanism of Securinine in Ovarian Cancer"],"prefix":"10.1007","volume":"32","author":[{"given":"Xin-min","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-yu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-heng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-yin","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"4246_CR1","doi-asserted-by":"publisher","first-page":"216057","DOI":"10.1016\/j.canlet.2023.216057","volume":"555","author":"RL Hollis","year":"2023","unstructured":"Hollis RL. Molecular characteristics and clinical behaviour of epithelial ovarian cancers. Cancer Lett 2023;555:216057.","journal-title":"Cancer Lett"},{"key":"4246_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209\u2013249.","journal-title":"CA Cancer J Clin"},{"key":"4246_CR3","doi-asserted-by":"publisher","first-page":"157023","DOI":"10.1016\/j.phymed.2025.157023","volume":"145","author":"B Han","year":"2025","unstructured":"Han B, Sun CT, Yang RW, Li X, Kang J, Cai JY, et al. Dihydrotanshinone I inhibits ovarian tumor growth by suppressing ITGB1\/FAK-mediated extracellular matrix signaling. Phytomedicine 2025;145:157023.","journal-title":"Phytomedicine"},{"key":"4246_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13073-021-00922-x","volume":"13","author":"S Olbrecht","year":"2021","unstructured":"Olbrecht S, Busschaert P, Qian J, Vanderstichele A, Loverix L, Van Gorp T, et al. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification. Genome Med 2021;13:111.","journal-title":"Genome Med"},{"key":"4246_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, International Natural Product Sciences Taskforce, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 2021;20:200\u2013216.","journal-title":"Nat Rev Drug Discov"},{"key":"4246_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 2020;83:770\u2013803.","journal-title":"J Nat Prod"},{"key":"4246_CR7","doi-asserted-by":"publisher","first-page":"154417","DOI":"10.1016\/j.phymed.2022.154417","volume":"106","author":"CJ Liu","year":"2022","unstructured":"Liu CJ, Fan XD, Jiang JG, Chen QX, Zhu W. Potential anticancer activities of securinine and its molecular targets. Phytomedicine 2022;106:154417.","journal-title":"Phytomedicine"},{"key":"4246_CR8","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1039\/D2NP00091A","volume":"40","author":"BK Mize","year":"2023","unstructured":"Mize BK, Salvi A, Ren Y, Burdette JE, Fuchs JR. Discovery and development of botanical natural products and their analogues as therapeutics for ovarian cancer. Nat Prod Rep 2023;40:1250\u20131270.","journal-title":"Nat Prod Rep"},{"key":"4246_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S1995-7645(12)60060-1","volume":"5","author":"DJ Kumar","year":"2012","unstructured":"Kumar DJ, Santhi RJ. Antioxidant and cytotoxic effects of hexane extract of Morinda pubescens leaves in human liver cancer cell line. Asian Pac J Trop Med 2012;5:362\u2013366.","journal-title":"Asian Pac J Trop Med"},{"key":"4246_CR10","doi-asserted-by":"publisher","first-page":"112727","DOI":"10.1016\/j.biopha.2022.112727","volume":"148","author":"N Bhagya","year":"2022","unstructured":"Bhagya N, Chandrashekar KR. Autophagy and cancer: can tetrandrine be a potent anticancer drug in the near future? Biomed Pharmacother 2022;148:112727.","journal-title":"Biomed Pharmacother"},{"key":"4246_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12032-024-02413-6","volume":"41","author":"Y Yang","year":"2024","unstructured":"Yang Y, Huang L, Gao J, Qian B. Salvianolic acid B inhibits the growth and metastasis of A549 lung cancer cells through the NDRG2\/PTEN pathway by inducing oxidative stress. Med Oncol 2024;41:170.","journal-title":"Med Oncol"},{"key":"4246_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/08923973.2026.2632299","volume":"48","author":"XM Zhong","year":"2026","unstructured":"Zhong XM, Chen JJ, Jiang B, Zeng Y, Du CQ. Breviscapine inhibits the proliferation and immune escape of diffuse large B-cell lymphoma cells by regulating JAK2\/STAT3\/PD-L1 pathway. Immunopharmacol Immunotoxicol 2026;48:213\u2013223.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"4246_CR13","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1080\/07391102.2023.2227712","volume":"42","author":"AB Thakkar","year":"2024","unstructured":"Thakkar AB, Subramanian RB, Thakkar SS, Thakkar VR, Thakor P. Isolation, identification, and characterization of \u03b1-asarone, from hydromethanolic leaf extract of Acorus calamus L. and its apoptosis-inducing mechanism in A549 cells. J Biomol Struct Dyn 2024;42:5515\u20135535.","journal-title":"J Biomol Struct Dyn"},{"key":"4246_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1210\/endocr\/bqad176","volume":"165","author":"CS Callaway","year":"2023","unstructured":"Callaway CS, Mouchantat LM, Bitler BG, Bonetto A. Mechanisms of ovarian cancer-associated cachexia. Endocrinology 2023;165:176.","journal-title":"Endocrinology"},{"key":"4246_CR15","doi-asserted-by":"publisher","first-page":"1277243","DOI":"10.3389\/fimmu.2023.1277243","volume":"14","author":"KY Miao","year":"2023","unstructured":"Miao KY, Liu WC, Xu JT, Qian ZT, Zhang QL. Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy. Front Immunol 2023;14:1277243.","journal-title":"Front Immunol"},{"key":"4246_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12943-024-02213-6","volume":"24","author":"SQ Li","year":"2025","unstructured":"Li SQ, Chen X, Shi H, Yi M, Xiong B, Li TY. Tailoring traditional Chinese medicine in cancer therapy. Mol Cancer 2025;24:27.","journal-title":"Mol Cancer"},{"key":"4246_CR17","first-page":"817","volume":"23","author":"Y Liu","year":"2009","unstructured":"Liu Y, Yue ZH, Zhang N, Li J. Development of research on securinine. Chin Pharm Affairs (Chin) 2009;23:817\u2013818,828.","journal-title":"Chin Pharm Affairs (Chin)"},{"key":"4246_CR18","doi-asserted-by":"publisher","first-page":"154284","DOI":"10.1016\/j.phymed.2022.154284","volume":"104","author":"CC Li","year":"2022","unstructured":"Li CC, Wang L, Zhao JB, Wei YC, Zhai S, Tan M, et al. Lonicera rupicola Hook.f.et Thoms flavonoids ameliorated dysregulated inflammatory responses, intestinal barrier, and gut microbiome in ulcerative colitis via PI3K\/AKT pathway. Phytomedicine 2022;104:154284.","journal-title":"Phytomedicine"},{"key":"4246_CR19","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.tips.2019.10.004","volume":"40","author":"S Guardiola","year":"2019","unstructured":"Guardiola S, Varese M, Sanchez-Navarro M, Giralt E. A third shot at EGFR: new opportunities in cancer therapy. Trends Pharmacol Sci 2019;40:941\u2013955.","journal-title":"Trends Pharmacol Sci"},{"key":"4246_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3923\/ijp.2024.874.882","volume":"20","author":"ZH Wu","year":"2024","unstructured":"Wu ZH, Yibulayin W, He D, Xu KM, Yibulayin X, Ma L, et al. EGFR and K-ras gene mutations in the diagnosis of non-small cell lung cancer and their pathological correlation. Int J Pharmacol 2024;20:874\u2013882.","journal-title":"Int J Pharmacol"},{"key":"4246_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11655-025-4150-0","volume":"32","author":"CC Zhang","year":"2026","unstructured":"Zhang CC, Zhang JY, Liu Y, Wang XX, Gao DQ, Chen ZH, et al. Efficacy and safety of different types of traditional Chinese medicine preparations combined with EGFRTKIs for patients with non-small cell lung cancer: a network meta-analysis. Chin J Integr Med 2026;32:157\u2013164.","journal-title":"Chin J Integr Med"},{"key":"4246_CR22","doi-asserted-by":"publisher","first-page":"200185","DOI":"10.1016\/j.ctmp.2024.200185","volume":"6","author":"N Bai","year":"2025","unstructured":"Bai N, Guo Y, Zhou M, Chen J, Lin X, Liu X, et al. Rhodiola rosea L. improves the immunosuppressive microenvironment through the HIF-1\u03b1\/TGF-\u03b2\/Smad signaling pathway in breast cancer. Clin Tradit Med Pharmacol 2025;6:200185.","journal-title":"Clin Tradit Med Pharmacol"},{"key":"4246_CR23","doi-asserted-by":"publisher","first-page":"12133","DOI":"10.3390\/ijms241512133","volume":"24","author":"ZA Rashid","year":"2023","unstructured":"Rashid ZA, Bardaweel SK. Novel matrix metalloproteinase-9 (MMP-9) inhibitors in cancer treatment. Int J Mol Sci 2023;24:12133.","journal-title":"Int J Mol Sci"},{"key":"4246_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","volume":"80","author":"D Tewari","year":"2022","unstructured":"Tewari D, Patni P, Bishayee A, Sah AN, Bishayee A. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy. Semin Cancer Biol 2022;80:1\u201317.","journal-title":"Semin Cancer Biol"},{"key":"4246_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","volume":"43","author":"YM Hu","year":"2024","unstructured":"Hu YM, Dong ZG, Liu KD. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery. J Exp Clin Cancer Res 2024;43:23.","journal-title":"J Exp Clin Cancer Res"},{"key":"4246_CR26","doi-asserted-by":"publisher","first-page":"101042","DOI":"10.1016\/j.drup.2023.101042","volume":"73","author":"YF Li","year":"2024","unstructured":"Li YF, Zhao BW, Peng JZ, Tang HL, Wang SC, Peng SC, et al. Inhibition of NF-kappaB signaling unveils novel strategies to overcome drug resistance in cancers. Drug Resist Updat 2024;73:101042.","journal-title":"Drug Resist Updat"},{"key":"4246_CR27","doi-asserted-by":"publisher","first-page":"113755","DOI":"10.1016\/j.yexcr.2023.113755","volume":"431","author":"N Maimaitiaili","year":"2023","unstructured":"Maimaitiaili N, Zeng YX, Ju PN, Zhakeer G, E GX, Yao HY, et al. NLRC3 deficiency promotes hypoxia-induced pulmonary hypertension development via IKK\/NF-kappaB p65\/HIF-1alpha pathway. Exp Cell Res 2023;431:113755.","journal-title":"Exp Cell Res"},{"key":"4246_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s11655-024-3803-8","volume":"30","author":"QY Mao","year":"2024","unstructured":"Mao QY, Wang XQ, Lin F, Yu MW, Fan HT, Zheng Q, et al. Scorpiones, Scolopendra and Gekko inhibit lung cancer growth and metastasis by ameliorating hypoxic tumor microenvironment via PI3K\/AKT\/mTOR\/HIF-1alpha signaling pathway. Chin J Integr Med 2024;30:799\u2013808.","journal-title":"Chin J Integr Med"},{"key":"4246_CR29","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s11655-025-3832-y","volume":"31","author":"SY Liu","year":"2025","unstructured":"Liu SY, Zhang XW, Gao G, Liu CX, Chen H, Fu ZX, et al. Pseudolaric acid B alleviates non-alcoholic fatty liver disease by targeting PPARalpha to regulate lipid metabolism and promote mitochondrial biogenesis. Chin J Integr Med 2025;31:877\u2013888.","journal-title":"Chin J Integr Med"},{"key":"4246_CR30","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/cells12121572","volume":"12","author":"N Wagner","year":"2023","unstructured":"Wagner N, Wagner KD. Recent insights into the role of PPARs in disease. Cells 2023;12:1572.","journal-title":"Cells"},{"key":"4246_CR31","doi-asserted-by":"publisher","first-page":"46253","DOI":"10.18632\/oncotarget.10086","volume":"7","author":"ZY Tang","year":"2016","unstructured":"Tang ZY, Shen Q, Xie H, Zhou XY, Li J, Feng J, et al. Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC). Oncotarget 2016;7:46253\u201346262.","journal-title":"Oncotarget"},{"key":"4246_CR32","doi-asserted-by":"publisher","first-page":"104504","DOI":"10.1016\/j.drudis.2025.104504","volume":"30","author":"W Warren","year":"2025","unstructured":"Warren W, Osborn M, Yates A, O\u2019Sullivan S. The emerging role of fatty acid-binding protein 3 (FABP3) in cancer. Drug Discov Today 2025;30:104504.","journal-title":"Drug Discov Today"},{"key":"4246_CR33","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1021\/bi700047a","volume":"46","author":"SD Ayers","year":"2007","unstructured":"Ayers SD, Nedrow KL, Gillilan RE, Noy N. Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4. Biochemistry 2007;46:6744\u20136752.","journal-title":"Biochemistry"},{"key":"4246_CR34","doi-asserted-by":"publisher","first-page":"117152","DOI":"10.1016\/j.bcp.2025.117152","volume":"241","author":"X Zhao","year":"2025","unstructured":"Zhao X, Wang RH, Xia X, Han CC, Wei W, Zhao WZ, et al. Rhein suppresses osteosarcoma progression via modulating the miR-328-3p\/TCF7L2\/FABP4 axis. Biochem Pharmacol 2025;241:117152.","journal-title":"Biochem Pharmacol"},{"key":"4246_CR35","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.3390\/ijms23137444","volume":"24","author":"T Dank\u00f3","year":"2022","unstructured":"Dank\u00f3 T, Pet\u0151v\u00e1ri G, Raffay R, Sztankovics D, Moldvai D, Vetl\u00e9nyi E, et al. Characterisation of 3D bioprinted human breast cancer model for in vitro drug and metabolic targeting. Int J Mol Sci 2022;24:7444.","journal-title":"Int J Mol Sci"},{"key":"4246_CR36","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/ncb2877","volume":"15","author":"J Xie","year":"2013","unstructured":"Xie J, Proud CG. Crosstalk between mTOR complexes. Nat Cell Biol 2013;15:1263\u20131265.","journal-title":"Nat Cell Biol"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-026-4246-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:21:38Z","timestamp":1790158898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-026-4246-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4246"],"URL":"https:\/\/doi.org\/10.1007\/s11655-026-4246-1","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"1 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}